Absci Corp is trading 5.7% down at $5.99 as investors take profits ahead of a company presentation and after a strong late-May rally.
- The stock is pulling back following a surge of more than 30% in the last week of May, driven by positive analyst ratings.
- Absci is scheduled to present at the Jefferies Global Healthcare Conference on the morning of June 3, an event that could provide updates on its AI-driven drug discovery platform.
- The decline also comes amid broader market weakness, which is adding to the pressure on recent high-flying stocks.